The core network in absence epilepsy Differences in cortical and thalamic BOLD response

Grants

Funding Acknowledgements

Study funding: Supported by Pfizer Inc. (Neuroscience Research Grant), the National Health and Medical Research Council of Australia (NHMRC), and the Dowd Foundation (P. W. C.).Dr. Carney has received scholarship support from the Dowd Foundation. Dr. Masterton and Dr. Harvey report no disclosures. Prof. Scheffer has served on scientific advisory boards for and received funding for travel from UCB and Janssen-Cilag EMEA; serves on the editorial boards of the Annals of Neurology and Epilepsia; may accrue future revenue on pending patents re: Therapeutic Compound; has received speaker honoraria from UCB, Janssen-Cilag EMEA, and Eli Lilly and Company; and receives/has received research support from the NHMRC, Health Research Council of New Zealand, The University of Melbourne, the Jack Brockhoff Foundation, and the Perpetual Charitable Trustees. Prof. Berkovic has served on scientific advisory boards for UCB and Janssen-Cilag EMEA; has received funding for travel and honoraria from UCB; serves/has served on the editorial boards of Brain and Epileptic Disorders; and has received research support from UCB, the NHMRC, and the American Epilepsy Society. Prof. Jackson serves on a scientific advisory board for Neurosciences Victoria; receives royalties from the publication of Magnetic Resonance in Epilepsy, 2<SUP>nd</SUP> ed. (Elsevier, 2005); and receives/has received research support from the NHMRC.